Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -16,709 | -6,102 | -3,126 | N/A |
| Depreciation Amortization | 190 | 88 | 25 | N/A |
| Accounts payable and accrued liabilities | 810 | 281 | 103 | N/A |
| Other Working Capital | 2,277 | 457 | 148 | N/A |
| Other Operating Activity | 3,074 | -45 | -75 | 0 |
| Operating Cash Flow | $-10,358 | $-5,321 | $-2,925 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,001 | -174 | -292 | N/A |
| Other Investing Activity | -102 | -10 | -27 | 0 |
| Investing Cash Flow | $-1,103 | $-184 | $-319 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 2,000 | 944 | 500 | N/A |
| Debt Repayment | -400 | N/A | N/A | N/A |
| Common Stock Issued | -811 | N/A | 5 | N/A |
| Other Financing Activity | 123,203 | 0 | 8,930 | 0 |
| Financing Cash Flow | $123,992 | $944 | $9,435 | $N/A |
| Beginning Cash Position | 1,654 | 6,215 | 24 | N/A |
| End Cash Position | 114,185 | 1,654 | 6,215 | N/A |
| Net Cash Flow | $112,531 | $-4,561 | $6,191 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -10,358 | -5,321 | -2,925 | N/A |
| Capital Expenditure | -1,001 | -174 | -292 | N/A |
| Free Cash Flow | -11,359 | -5,495 | -3,217 | 0 |